FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Factor patents



      
           
This page is updated frequently with new Factor-related patent applications. Subscribe to the Factor RSS feed to automatically get the update: related Factor RSS feeds. RSS updates for this page: Factor RSS RSS


Date/App# patent app List of recent Factor-related patents
02/26/15
20150059022
 Genes controlling plant root growth and development for stress tolerance and  their use patent thumbnailnew patent Genes controlling plant root growth and development for stress tolerance and their use
Microarrays are employed to analyze soybean transcriptome under water stress conditions in different regions of the root at vegetative stage. Drought responsive genes and transcription factors are identified which may be used for enhancing drought tolerance in soybean or other plants through genetic/metabolic engineering.
The Curators Of The University Of Missouri
02/26/15
20150059014
 Polynucleotides and polypeptides in plants patent thumbnailnew patent Polynucleotides and polypeptides in plants
The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods and is also disclosed..
Mendel Biotechnology, Inc.
02/26/15
20150058996
 Gap services router (gsr) patent thumbnailnew patent Gap services router (gsr)
A gap services router (gsr) that is a drop-in replacement of an end of life cisco™ 2811 integrated services router (isr). The gsr is a routing, switching, and computing platform that provides a technology refresh in the same form factor as the legacy 2811 router.
Telecommunication Systems, Inc.
02/26/15
20150058276
 Data processing apparatus, data processing method, and program patent thumbnailnew patent Data processing apparatus, data processing method, and program
Devices, methods, and programs for monitoring electrical devices. A method for monitoring an electrical device may include obtaining data representing a sum of electrical signals of electrical devices; processing the data with a factorial hidden markov model (fhmm) to produce an estimate of an electrical signal of a first of the electrical devices; and outputting the estimate of the electrical signal of the first electrical device.
Informetis Corporation
02/26/15
20150057336
 Rnai-related inhibition of tnf alpha signaling pathway for treatment of glaucoma patent thumbnailnew patent Rnai-related inhibition of tnf alpha signaling pathway for treatment of glaucoma
Rna interference is provided for inhibition of tumor necrosis factor α (tnfα) by silencing tnfα cell surface receptor tnf receptor-1 (tnfr1) mrna expression, or by silencing tnfα converting enzyme (tace/adam17) mrna expression. Silencing such tnfα targets, in particular, is useful for treating patients having a tnfα-related condition or at risk of developing a tnfα-related condition such as the ocular conditions associated with elevated intraocular pressure (top), including glaucoma and ocular hypertension..
Alcon Research, Ltd.
02/26/15
20150057262
 Cyclic p1 linkers as factor xia inhibitors patent thumbnailnew patent Cyclic p1 linkers as factor xia inhibitors
Or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor xia inhibitors or dual inhibitors of fxia and plasma kallikrein.
02/26/15
20150057228
 Antidotes for factor xa inhibitors and methods of using the same patent thumbnailnew patent Antidotes for factor xa inhibitors and methods of using the same
The present invention relates antidotes to anticoagulants targeting factor xa. The antidoes are factor xa protein derivatives that bind to the factor xa inhibitors thereby substantially neutralizing them but do not assemble into the prothrombinase complex.
Portola Pharmaceuticals, Inc.
02/26/15
20150057223
 High activity growth factor mutants patent thumbnailnew patent High activity growth factor mutants
The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.. .
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
02/26/15
20150056704
 Methods and products for biasing cellular development patent thumbnailnew patent Methods and products for biasing cellular development
Methods are described that bias cells, such as potent and multipotent stem cells, by transfection with a nucleic acid sequence, to differentiate to a desired end-stage cell or a cell having characteristics of a desired end-stage cell. In particular embodiments, human neural stem cells are transfected with vectors comprising genes in the homeobox family of transcription factor developmental control genes, and this results in a greater percentage of resultant transformed cells, or their progeny, differentiating into a desired end-stage cell or a cell having characteristics of a desired end-stage cell..
University Of Central Florida Research Foundation, Inc.
02/26/15
20150056271
 Compositions and methods for enhancing coagulation factor viii function patent thumbnailnew patent Compositions and methods for enhancing coagulation factor viii function
factor viii variants and methods of use thereof are disclosed.. .
The Children's Hospital Of Philadelphia
02/26/15
20150056211
new patent

Heparin-binding epidermal growth factor-like growth factor binding proteins


Provided herein are antigen binding proteins, e.g., human and/or monoclonal antibodies that have affinity for heparin-binding epidermal growth factor-like growth factor (hb-egf) and neutralize the biological functions of this growth factor.. .
Amgen, Inc.
02/26/15
20150056207
new patent

Combination therapy with c-met and egfr antagonists


The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to combination therapies for the treatment of pathological conditions, such as cancer..
Genentech, Inc.
02/19/15
20150052641

Control of cellulose biosynthesis by overexpression of a transcription factor


The invention relates to the over-expression of a transcription factor selected from the group consisting of myb46, ham1, ham2, myb112, wrky11, erf6, and any combination thereof in a plant, which can modulate and thereby modulating the cellulose content of the plant.. .
Board Of Trustees Of Michigan State University
02/19/15
20150051838

System and determining and optimizing waterflood performance


A system and method of map based assessment of waterflood are provided. The method includes generating a water injection influence (wii) map by mapping one or more connectivity parameters derived from a capacitance resistance model; calculating a recovery factor (rf) and pore volumes injected (pvi) for each injector influence region in one or more influence regions defined from the connectivity parameters; determining a maximum of the recovery factor versus the pore volume injected using a curve fit extrapolation; determining a volume of injection water needed or a number of injectors needed based on recovery factor versus pore volumes injected; calculating a voidage replacement ratio (vrr) within each injector influence region; determining a target voidage replacement ratio by selecting an average voidage replacement ratio with a most recent interval of time; and determining a number of infill wells with drilling schedule to maintain the determined target voidage ratio..
Chevron U.s.a. Inc.
02/19/15
20150051156

Method of treating leukemia using rice prolamin


The present invention relates to a method of treating leukemia using rice prolamin, comprising administering a daily dose of isolated prolamin to a patient suffering from leukemia for a period of time from 5 days to 10 days. For the treatment application, the rice prolamin can stimulate human peripheral blood mononuclear cell (pbmc) to produce cytokines, such as tumor necrosis factor-alpha, to inhibit growth of and induce differentiation of human leukemia cells.
Mackay Memorial Hospital
02/19/15
20150051146

Hb-egf inhibitor derived from the r domain of diphtheria toxin for the treatment of diseases associated with the activation of the hb-egf/egfr pathway


A ligand recombinant protein inhibiting hb-egf (heparin-binding epidermal growth factor like), from the r domain of diphtheria toxin, which can be used for the treatment and diagnosis of diseases involving the activation of the hb-egf/egfr pathway.. .
Commissariat A L'energie Atomique Et Aux Ene Alt
02/19/15
20150051091

Methods of selecting epidermal growth factor receptor (egfr) binding agents


The present application relates to methods of selecting egfr binding agents. In certain embodiments, such egfr binding agents bind to at least a portion of a panitumumab epitope on an egfr.
02/19/15
20150050964

Low radiation dose rate mobile phone


The field of the invention relates to mobile phones arranged to reduce a specific absorption rate of mobile phone radiation into the body of a user. There is provided a bar form factor mobile phone device comprising front and back major faces, the front major face arranged to present a first display screen and the back major face arranged to present a second display screen, wherein the device comprises an antenna operable to receive radio frequency transmissions, wherein the first and second displays have low transmission at the radio frequency transmissions, and wherein the antenna is arranged near to a side face of the device..
Yota Devices Ipr Ltd
02/19/15
20150050927

Signaling support for devices with multiple and/or flexible form factors


Systems, methods, apparatuses, and computer program products for signaling support for devices with multiple and/or flexible form factors are provided. One method includes determining, by a device having multiple forms and associated with a network, a current form or a change in the form of the device, determining new parameters according to the determined current form of the device, and reporting the new parameters to the network..
Nokia Corporation
02/19/15
20150050627

Prophylactic kit apparatus


A prophylactic kit apparatus configured to be used with only a single patient includes a plurality of sealed modules and a housing configured to contain those sealed modules such that only one of the plurality of sealed modules can be removed from the housing at a time. This kit may include a physically-discrete informational patient aid disposed within the housing and having information disposed thereon.
02/19/15
20150050332

Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration


In various embodiments, the present invention describes materials and methods for the local reprogramming of cells in a location where the treatment is applied. The invention can be used to replace lost cells or to restore function to tissue damaged due to disease, injury or genetic defect.
02/19/15
20150050331

Method for making a topical composition comprising growth factors derived from human umbilical cord blood platelets


The present invention is directed to a method of making a stable composition comprising growth factors, which may include platelet derived growth factors and transforming growth factors. The method comprises providing human umbilical cord blood plasma containing platelets, but substantially free of whole blood cells, and lysing the platelets to extrude growth factors into the plasma.
Novo Solutions Md, Llc
02/19/15
20150049102

Method and the progressive loading of medical multidimensional images into a medical application


A method includes a) loading a first number n of image sets with an image size ky, the ky images of which are distributed in a regular manner over a volume, which is to be loaded in its entirety as a result; b) loading a number nx of image sets starting with a factor x=1, with the images loaded in total being distributed in a regular manner over the volume; c) determining a camera distance and voxel size based on the number of images loaded, a camera distance and voxel size being suitable as parameters for a volume rendering; and d) repeating the two preceding steps b) and c) while increasing the number of image sets with a factor x=x+1, until all the images of the volume have been loaded in their entirety and/or until the step sequence ends.. .
Siemens Aktiengesellschaft
02/19/15
20150048641

Universal console chassis for the car


Methods and systems for a complete vehicle ecosystem are provided. Specifically, systems that when taken alone, or together, provide an individual or group of individuals with an intuitive and comfortable vehicular environment.
Flextronics Ap, Llc
02/19/15
20150048465

Small form factor magnetic shield for magnetorestrictive random access memory (mram)


Some implementations provide a die that includes a magnetoresistive random access memory (mram) cell array that includes several mram cells. The die also includes a first ferromagnetic layer positioned above the mram cell array, a second ferromagnetic layer positioned below the mram cell array, and several vias positioned around at least one mram cell.
Qualcomm Incorporated
02/19/15
20150048178

Systems, methods and articles to provide olfactory sensations


A system to provide scents includes a scent receiver to replaceable receive scent carriers that carry scent media, a scent actuator operable to controllable release scent, and a configurable circulation subsystem. Peltier devices may used to induce active heating and active cooling of scent media according to defined scent sequence information or scent tracks.
02/12/15
20150046756

Predictive failure analysis to trigger rebuild of a drive in a raid array


An apparatus comprising a first interface, a second interface and a processor. The first interface may be configured to connect to a host device.
Lsi Corporation
02/12/15
20150046124

End of life detection for analyte sensors


Systems and methods for processing sensor data and end of life detection are provided. In some embodiments, a method for determining the end of life of a continuous analyte sensor includes evaluating a plurality of risk factors using an end of life function to determine an end of life status of the sensor and providing an output related to the end of life status of the sensor.
Dexcom, Inc.
02/12/15
20150046113

End of life detection for analyte sensors


Systems and methods for processing sensor data and end of life detection are provided. In some embodiments, a method for determining the end of life of a continuous analyte sensor includes evaluating a plurality of risk factors using an end of life function to determine an end of life status of the sensor and providing an output related to the end of life status of the sensor.
Dexcom, Inc.
02/12/15
20150045425

Peltatin and metabolic disorders


The present invention relates to the field of metabolic disorders and aims to identify natural compounds that can be used effectively in this field. In particular, the present invention provides a composition comprising at least one peltatin for use in the treatment or prevention of metabolic disorders or risk factors thereof..
Nestec S.a.
02/12/15
20150045406

Curaxins for use in treating breast cancer and identifing patients likely to respond


The present invention relates to the treatment of breast cancer which is estrogen receptor positive (er+) and/or human epidermal growth factor receptor 2 positive (her2) and/or progesterone receptor positive (pr) and/or facilitates chromatin transcription positive (fact+) with a curaxin, including curaxin 137. The present invention also pertains to a method of identifying a subject who has a breast cancer tumor and is likely to respond to treatment with a curaxin..
Incuron, Llc
02/12/15
20150044769

Cell line adapted to a protein-free and lipid-free medium, a producing the cell line, and a medium for the cell line


A cell of a cell line adapted to a protein-free and lipid-free medium, which is derived from cho cells, can be stably used for production of recombinant proteins and can proliferate in a suspended state in a protein-free and lipid-free medium containing no exogenous growth factors. A method for adapting cho cells by using a protein-free and lipid-free medium and a medium used for the method..
Kyokuto Pharmaceutical Industrial Co., Ltd.
02/12/15
20150044719

Method for producing a recombinant protein using a cell line adapted to a protein-free and lipid-free medium


A method for producing a recombinant protein includes steps of: (a) culturing a transformed cell in a protein-free and lipid-free medium containing no exogenous growth factors, in which the transformed cell is produced by transfecting a cell of a cell line derived from chinese hamster ovary (cho) cells, the cell line is adapted to a protein-free and lipid-free medium, and the cell is capable of proliferating in a suspended state in a protein-free and lipid-free medium containing no exogenous growth factors, with a vector containing a gene coding for the protein to be produced under the control of a promoter operable in the cell, and (b) recovering the protein produced by the transformed cell.. .
Kyokuto Pharmaceutical Industrial Co., Ltd.
02/12/15
20150044259

Scaffold for enhanced neural tissue regeneration


This application discloses a scaffold for promoting the growth of a nerve in a mammal while minimizing clumping, which comprises a support structure having an elongate opening formed therein and configured for placement around a damaged region of a nerve and a physiologically acceptable matrix composition in said opening, said matrix composition comprising a poly-d lysine (pdl) and a peptidoglycan, and nerve growth factor (ngf).. .
02/12/15
20150044237

Chimeric molecule involving oligomerized fasl extracellular domain


New chimeric molecules involving in their structure, a combination of the extracellular domain (ec) of the fasl protein and a domain enabling oligomerisation of this fas ligand (fasl) ec domain, such as the ig-like (so-called ig in the following pages) domain of the gp190 receptor for the leukemia inhibitory factor (lif), or involving in their structure variants of the domains. Also, compositions including the chimeric molecule defined herein and the use of these chimeric molecules especially to trigger cytotoxic activity toward cells sensitive to fasl..
Centre National De La Recherche Scientifique
02/12/15
20150044220

Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer


Epidermal growth factor receptor (egfr) expression and phosphorylation is increased in cancer cells treated with anti-clusterin antibodies. Such treatment is also accompanied with the reappearance of an epithelial phenotype of the cancer cell, as determined by an increased e-cadherin expression at the surface of cancer cells.
Alethia Biotherapeutics Inc.
02/12/15
20150044195

Fviia-stf complexes exhibiting exosite-mediated super activity


Disclosed are disulphide-linked complexes of a soluble tissue factor (stf) variant of seq id no:3 comprising the mutation g109c and a factor viia variant of seq id no. 1, comprising the mutation q64c and a mutation at position m306 that gives rise to a zymogen-like conformation in the factor viia polypeptide.
Novo Nordisk Healthcare Ag
02/12/15
20150044178

Normalization of culture of corneal endothelial cells


The present invention provides a method for the normalized culturing of corneal endothelial cells. More specifically, the present invention provides a culture-normalizing-agent of a corneal endothelial cell, comprising a fibrosis inhibitor.
The Doshisha
02/12/15
20150044166

Compositions and methods for treatment of exercise-induced pulmonary hemorrhage or nasopharyngeal cicatrix


Methods, compositions, and medical device systems relating to treating exercise-induced pulmonary hemorrhage (eiph) and nasopharyngeal cicatrix (nc) in a mammal. For example, one method comprises administering through inhalation a composition comprising a physiologically acceptable carrier and an effective amount of each of one or more stem cell derived factors.
Riddle Institute
02/12/15
20150041614

Flexible mounting mounting an antenna


A mounting apparatus (102) comprises a plurality of flexible interconnected spacer segments (104) for receiving the antenna (106), the plurality of flexible interconnected spacer segments provide a continuous offset (114) between the antenna and another surface. Each of the plurality of flexible interconnected spacer segments (104) comprises a unitarily molded flexible link, each link having a triangular cross sectional geometry (350) having an opening (108) on top (302) for receiving the antenna, and the top leading to a wider base for mounting to a surface.
Motorola Solutions, Inc.
02/05/15
20150039359

Component based mobile architecture with intelligent business services to build extensible supply chain ready procurement platforms


The present invention is a tool for managing spend analysis, reverse auctions, sourcing, contracts, procure-to-pay processes, requests for proposals, supplier assessment and settlement processes. It employs hardware architecture and a software framework to provide a platform as a service that allows the user to create, store, report and manage bids, requests for proposals, contracts, bid data, spend analysis, and supplier scoring information from any of a number of mobile devices of various form factors..
02/05/15
20150039351

Categorizing life insurance applicants to determine suitable life insurance products


Methods and apparatuses, including computer program products, are described for categorizing a life insurance applicant to determine one or more suitable insurance products. A computing device receives data associated with the applicant.
Transamerica Corporation
02/05/15
20150039254

Data processing device, data processing method, and program


A data processing device includes: a data obtaining section obtaining time series data on a total value of current consumed by a plurality of electric apparatuses; and a parameter estimating section obtaining a model parameter when states of operation of the plurality of electric apparatuses are modeled by a factorial hmm on a basis of the obtained time series data.. .
Sony Corporation
02/05/15
20150038559

Pharmaceutical composition and the treatment of neurodegenerative diseases, in particular amyotrophic lateral sclerosis


A pharmaceutical composition and method for therapy of neurodegenerative diseases including amyotrophic lateral sclerosis, the composition comprising an adenoviral vector, expressing a human angiogenesis factor gene; an effective amount of the adenoviral vector in the form of a non-replicating nanoparticle based on a genome of human adenovirus type 5 with an insertion of a human angiogenin gene which produces the human angiogenesis in a human body; a non-replicating nanoparticle based on the genome of human adenovirus type 5 with an insertion of a human vascular endothelium growth factor gene; and a formulating buffer; wherein the human angiogenin factor gene and the human vascular endothelium growth factor gene are cloned in two expression cassettes within one non-replicating nanoparticle based on the genome of human adenovirus type 5.. .
Ooo "ntpharma"
02/05/15
20150038443

Transcription factor inhibitors and related compositions, formulations and methods


The present invention provides small molecules useful to affect cancer cells, along with related methods. The present compounds, formulations, kits and methods are useful for a variety of research, diagnostic and therapeutic purposes.
The Ohio State University
02/05/15
20150038422

Unit dosage forms of pharmaceutical compositions comprising a polymer-factor viii polypeptide conjugate


Conjugates of a factor viii moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof.
Nektar Therapeutics
02/05/15
20150038421

Factor viii compositions and methods of making and using same


The present invention relates to compositions comprising factor viii coagulation factors linked to extended recombinant polypeptide (xten), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor viii-related diseases, disorders, and conditions.. .
Amunix Operating Inc.
02/05/15
20150038419

Simukunin


The present invention includes a novel protein, also referred to herein as simukunin, that inhibits the function of several physiologically important enzymes. Simukunin is a potent inhibitor of the blood coagulation cascade, inhibiting factor xa and functioning as an efficient anticoagulant.
University Of Georgia Research Foundation, Inc.
02/05/15
20150038371

Transformed human pluripotent stem cells and associated methods


The present disclosure provides transformed human pluripotent stem cell (t-hpsc). T-hpscs are not dependent on oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor nanog.
Mcmaster University
02/05/15
20150038338

Identification of olfactory receptors sensitive to different odorants


This disclosure provides methods for identification of olfactory sensosry neurons (osn) that recognize specific odorants. The method comprises introducing into the osn, a permanent activity marker which exhibits a detectable and permanent change upon activation of the neuron in response to an odorant and exposure to an exteranal stimulus, such as light.
New York University
02/05/15
20150038195

Amplifier and transmission solution for 13.56mhz radio coupled to smartmx smartcard controller


An rfid card includes a smartcard controller that receives power from a host device. The rfid card also includes a small inductive device capable of inductive coupling with an rfid reader.
Tyfone, Inc.
02/05/15
20150038194

Amplifier and transmission solution for 13.56mhz radio coupled to smartcard controller


An rfid card includes a smartcard controller that receives power from a host device. The rfid card also includes a small inductive device capable of inductive coupling with an rfid reader.
Tyfone, Inc.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Factor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Factor with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         









0.3896

3950

76 - 0 - 78